Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home ABOUT ABLYNX executive management > Wim Ottevaere

Executive Management

Wim Ottevaere, Chief Financial Officer

Wim Ottevaere holds a Master's degree in business economics from the University of Antwerp (UFSIA), Belgium. From 1978 until 1989, he held various positions in finance and administration within the Dossche group. From 1990 until 1992, he served as Finance Director of Vanhout, a subsidiary of the Besix group, a large construction enterprise in Belgium. From 1992 until July 2006, Wim was Chief Financial Officer of Innogenetics, a biotech company listed on Euronext. Wim joined Ablynx in August 2006.